(Q34564797)

3 August 2017

1 reference

title

Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance (English)

1 reference

3 August 2017

0 references

1 reference

antibiotic resistance

1 reference

1 reference

E Montassier

1

1 reference

3 August 2017

E Batard

2

1 reference

3 August 2017

T Gastinne

3

1 reference

3 August 2017

G Potel

4

1 reference

3 August 2017

M F de La Cochetière

5

1 reference

3 August 2017

25 January 2013

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

3 August 2017

1 reference

3 August 2017

32

1 reference

3 August 2017

841-850

1 reference

3 August 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1007/s10096-013-1819-7

3 August 2017

0 references

cites work

Management of fever in neutropenic patients with different risks of complications

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Contemporary antimicrobial susceptibility patterns of bacterial pathogens commonly associated with febrile patients with neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Clinical characteristics and prognostic factors of Acinetobacter nosocomialis bacteraemia in patients with solid tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

P. aeruginosa bloodstream infections among hematological patients: an old or new question?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Hematological: Low all-cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Bloodstream infections in adult patients with cancer: clinical features and pathogenic significance of Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Bacterial infection profiles in lung cancer patients with febrile neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Incidence of fluoroquinolone-resistant and extended-spectrum β-lactamase-producing Escherichia coli at a comprehensive cancer center in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Escherichia coli resistance to quinolones at a comprehensive cancer center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Blood stream infections in cancer patients: a single center experience of isolates and sensitivity pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Bacteraemia in febrile neutropenic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Effects on spectrum and susceptibility patterns of isolates causing bloodstream infection by restriction of fluoroquinolone prophylaxis in a hematology-oncology unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Impact of fluoroquinolone administration on the emergence of fluoroquinolone-resistant gram-negative bacilli from gastrointestinal flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Bacteremia due to quinolone-resistant Escherichia coli in a teaching hospital in South Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

Multidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-013-1819-7

High incidence of methicillin-resistant Staphylococcus aureus sepsis and death in patients with febrile neutropenia at Royal Darwin Hospital

21 January 2018

1 reference

12 December 2020

Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation

1 reference

12 December 2020

Bacterial isolates in neutropenic febrile patients

1 reference

12 December 2020

Profile of infections and outcome in high-risk febrile neutropenia: experience from a tertiary care cancer center in India

1 reference

12 December 2020

Febrile neutropenia in haematological malignancies.

1 reference

12 December 2020

High prevalence of extended spectrum beta-lactamase production among Klebsiella pneumoniae strains isolated at a University Hospital in Turkey

1 reference

12 December 2020

Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk

1 reference

12 December 2020

Characterization and anti-microbial susceptibility of gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan

1 reference

12 December 2020

Susceptibility surveillance among gram-negative bacilli at a cancer center

1 reference

12 December 2020

Clinical implications of chemotherapy-induced diarrhea in patients with cancer

1 reference

12 December 2020

Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome

1 reference

12 December 2020

Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients

1 reference

12 December 2020

Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies

1 reference

12 December 2020

Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients

1 reference

12 December 2020

Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study

1 reference

12 December 2020

10.1007/S10096-013-1819-7

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference